A Randomized Controlled Trial of Angiotensin-Converting Enzyme Inhibition for Skeletal Muscle Dysfunction in COPD-Reference-Cited by-同舟云学术

A Randomized Controlled Trial of Angiotensin-Converting Enzyme Inhibition for Skeletal Muscle Dysfunction in COPD

Published:2014-10 Issue:4 Volume:146 Page:932-940
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Shrikrishna Dinesh,Tanner Rebecca J.,Lee Jen Y.,Natanek Amanda,Lewis Amy,Murphy Patrick B.,Hart Nicholas,Moxham John,Montgomery Hugh E.,Kemp Paul R.,Polkey Michael I.,Hopkinson Nicholas S.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference32 articles.

1. The prevalence of quadriceps weakness in COPD and the relationship with disease severity;Seymour;Eur Respir J,2010

2. Quadriceps wasting and physical inactivity in patients with COPD;Shrikrishna;Eur Respir J,2012

3. Peripheral muscle weakness contributes to exercise limitation in COPD;Gosselink;Am J Respir Crit Care Med,1996

4. Chronic obstructive pulmonary disease: consequences beyond the lung;Shrikrishna;Clin Med,2012

5. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease;Swallow;Thorax,2007

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Musculoskeletal crosstalk in chronic obstructive pulmonary disease and comorbidities: Emerging roles and therapeutic potentials;Pharmacology & Therapeutics;2024-05

2. ACE I/D genotype associates with strength in sarcopenic men but not with response to ACE inhibitor therapy in older adults with sarcopenia: Results from the LACE trial;PLOS ONE;2023-10-20

3. Efficacy of interventions to alter measures of fat-free mass in people with COPD: a systematic review and meta-analysis;ERJ Open Research;2023-04-20

4. Could patients with chronic obstructive pulmonary disease benefit from renin angiotensin system inhibitors? A meta-analysis;BMJ Open Respiratory Research;2023-02

5. Targeting the renin angiotensin system for respiratory diseases;Advances in Pharmacology;2023